Clostridium difficile infection recurrence
Also known as: Recurrence of Clostridium Difficile Infection / Recurrent Clostridium Difficile Infection / Recurrent infection caused by Clostridioides difficile (disorder) / Clostridioides difficile infection / Clostridium difficile Infections / Clostridium difficile infection / Infection caused by Clostridioides difficile (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB13140 | Bezlotoxumab | A monoclonal antibody used to reduce the recurrence of Clostridium difficile infections. |
| DB01220 | Rifaximin | A rifamycin-based non-systemic antibiotic used for the treatment of gastrointestinal bacterial infections, such as traveler's diarrhea and irritable bowel syndrome, and reduction of overt hepatic encephalopathy recurrence in adults. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB17794 | VE303 | 2 | Completed | 1 |
| DB00512 | Vancomycin | 2 | Completed | 2 |
| DB00512 | Vancomycin | 2 / 3 | Terminated | 1 |
| DB17743 | Fecal microbiota | 3 | Completed | 1 |
| DB17743 | Fecal microbiota | 3 | Not Yet Recruiting | 1 |
| DB17743 | Fecal microbiota | 3 | Recruiting | 1 |
| DB08874 | Fidaxomicin | 3 | Completed | 1 |
| DB17794 | VE303 | 3 | Not Yet Recruiting | 1 |
| DB13140 | Bezlotoxumab | 4 | Completed | 1 |
| DB13140 | Bezlotoxumab | 4 | Unknown Status | 1 |
| DB00512 | Vancomycin | 4 | Completed | 1 |
| DB00512 | Vancomycin | 4 | Terminated | 1 |
| DB13140 | Bezlotoxumab | Not Available | Completed | 1 |
| DB17743 | Fecal microbiota | Not Available | Available | 1 |
| DB17743 | Fecal microbiota | Not Available | Recruiting | 1 |